本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cogent Biosciences, Inc.

12.08
0.0000
成交量:106.08万
成交额:1,274.48万
市值:16.88亿
市盈率:-4.79
高:12.21
开:12.08
低:11.88
收:12.08
52周最高:12.97
52周最低:3.72
股本:1.40亿
流通股本:9,913.91万
量比:1.10
换手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-2.5207
每股收益(LYR):-2.4616
净资产收益率:-107.55%
总资产收益率:-53.15%
市净率:35.81
市盈率(LYR):-4.91

数据加载中...

2024/08/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

SEC问询函

Form CORRESP - Correspondence
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]